.png){kind=icon}
今天的医疗环境是复杂的：付款人想要经过验证的“价值”。提供商希望解决方案以使其实践有效和高效。患者越来越多地参与决策。监管机构希望患者保护的更大边距。投资者想要令人信服的证据。智能发展伙伴是您成功的关键。
Unlike other medical device CROs, our strategic approach means we look at your project with both clinical and strategic eyes and adeptly apply our interdisciplinary knowledge throughout the duration of the process. We ask “why?” first, remain focused on the end goal and build on each project. And, as with any high-performance team, an interactive relationship is the foundation by which we achieve greater results together.
通过所有产品开发阶段支持您
从简单地修改市场发布的产品到新颖的组合产品，我们的深度经验和经过验证的综合方法有助于消除障碍，以加快主要监管机构和全球通知机构的批准。
我们的战略方法推动了市场成功
Because we scrutinize every detail of your product and business goals, we uncover opportunities, reduce cost and improve timelines. From the start you’ll be partnered with a truly collaborative and experienced team who will work side-by-side with you to move your discovery process and product toward the marketplace and keep it there.
Benefits of our strategic approach:
- Experience fewer regulatory hurdles
- Get products to patients sooner
- Become profitable sooner
Keeping the end in mind: A focus on ultimate success
通过服务跨越设备开发的服务 - 从早期手术原型，生物相容性，临床试验（包括分散和第四阶段），监管事务和报销计划 - 审议提供总价值，包括满足符合A需求的创新的洞察力和远见挑战性和不断变化的市场。我们的最终目标是成为帮助创新者为全球人民带来医疗解决方案的战略合作伙伴。
专家意识。确切的做法。有效的结果。Covance是医疗器械CRO，难以积极影响医疗器械创新。
